Targa Resources TRGP

Reference table

1. What it is

Targa Resources (NYSE: TRGP) is a Houston-based North American midstream energy company — infrastructure, not exploration. It gathers, compresses, treats, processes and transports natural gas, and it stores, fractionates, transports and exports natural gas liquids (NGLs) such as propane and butane, with a heavy geographic concentration in the Permian Basin feeding its Mont Belvieu, Texas fractionation and Gulf Coast LPG-export complex. Fiscal year ends December 31. CEO Matthew Meloy; ~3,370 employees.

Revenue mix (FY2025, from filings):

• By segment: Logistics & Transportation $14.56B (~85%) · Gathering & Processing $7.42B (~43%) · intersegment eliminations −$0.03B (segments overlap because G&P feeds L&T; percentages don't sum to 100). L&T — the fee-based fractionation, pipeline and export business — is the larger and more toll-like engine; G&P is more directly geared to wellhead volumes and commodity prices.
• By geography: FMP does not provide a country split for TRGP — the geographic table simply repeats the two operating segments, so we treat this as a domestically-concentrated US operator (with a Gulf Coast LPG-export channel to international buyers).

The strategic story is a multi-year build-out: new Permian processing plants (Falcon II, East Pembrook, Roadrunner III and Copperhead II announced), new Mont Belvieu fractionation trains (Train 11 online, 12/13 under construction), and NGL-pipeline and LPG-export expansions — all funded by ~$4.5B/yr of growth capex (§9).

2. The expert thesis (traceability)

There is no expert coverage of TRGP in the Synthos knowledge base. total_claims = 0; there are zero net-bullish voices and zero cautionary voices to cite. We will not manufacture conviction we don't have: this verdict is fundamentals- and quant-driven only, built from the FMP financials, analyst estimates, management's own SEC-filed guidance (half-weighted, §9), and the Synthos scoring framework. Where a claim ID would normally appear, there is none — by design, not omission. Read the Street consensus (§6) and management guidance (§9) as the only outside voices here, and weight them accordingly.

3. Synthos scores & the Bull / Base / Bear cases

The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):

The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. Instead the cases bound the range, and the scores above summarize them.

Synthos fair value = the base case, ~$270 (+4%), with the full $178–$336 span as the honest range. Our base sits essentially on top of the Street's $277 consensus — we are not more constructive than the sell-side here, and the thin ~4% base-case upside is precisely why the verdict is Watch, not Buy. This is a tracked call — the Forecaster Scorecard grades it once it matures.

4. Exponential Potential

Synthos separates compounders (durable returns on capital) from exponentials (accelerating, multi-baggers-from-here). TRGP is a respectable compounder, decidedly not an exponential:

• Forward growth: revenue CAGR FY25→FY30E ~12.7% ($17.1B → $31.2B est); EPS CAGR ~16.6% ($8.54 → $18.39 est) as fee-based EBITDA scales and share count shrinks.
• Acceleration (the 2nd derivative) is negative/lumpy: EBITDA grew FY23 $3.97B → FY24 $4.14B → FY25 $4.85B, and management guides FY26 adjusted EBITDA to $5.7–5.9B (+17% YoY) — healthy, but the estimate curve shows revenue growth slowing from the low-20s%s in FY27 toward high-single/low-double digits by FY29–30E. This is late-cycle build-out growth, not an inflection.
• Room to run: the constraint is real. The growth is levered to Permian NGL volumes and Gulf Coast export demand — a genuine multi-year tailwind, but a single-basin, single-commodity-family, mature-infrastructure story, not an open-ended TAM. At $56B in a cyclical sector, a 3–5× from here is not a credible base case.
• Reinvestment runway: heavy — $4.5B/yr growth capex — but it consumes nearly all operating cash flow (FY25 FCF just $584M), so the "reinvestment" story is real but low-conversion.

Exponential Potential: Low-Moderate (4/10). Own TRGP, if at all, for mid-teens EPS compounding plus a growing dividend, not for a fast multibagger. That honest framing is why it sits in a satellite income/energy sleeve, not the Core or Degen tiers.

5. Financials (real numbers — FMP annual/quarterly)

• Revenue: FY25 $17.14B, +3.1% (FY24 $16.63B, +6.5% on FY23 $15.62B). Reported revenue is commodity-flow inflated — the toll-economics that matter show up in EBITDA and margin, not the top line (product-purchase pass-throughs dominate cost of revenue).
• Quarterly trajectory: Q1'25 $4.85B → Q2 $4.03B → Q3 $4.20B → Q4 $4.06B → Q1'26 $4.09B. Revenue is lumpy with commodity prices; the cleaner tell is adjusted EBITDA — a record $1.40B in Q1'26, +19% YoY (management's figure).
• Margins (the real story): gross 29.9% TTM, EBITDA margin 30.4% TTM (up from ~25% in FY23), operating ~21%, net 13.0% TTM. Margin is expanding as the fee-based mix grows — the healthiest single trend in the financials.
• Earnings: net income $1.84B FY25 (+45% on FY24 $1.27B); EPS $8.54 (vs $5.77). Q1'26 net income $480M, EPS $2.23. The 2020–21 losses (EPS −$7.26 / −$0.07) are a reminder this is a cyclical business that can swing negative in an energy downturn.
• Cash flow (the weak spot): operating CF $3.92B FY25, capex −$3.33B (plus $2.0B of acquisitions), FCF just $584M. FCF yield ~0.5%, price/FCF >200×. The dividend ($818M paid FY25) plus buybacks exceed FCF, funded by net debt issuance — sustainable only while the build-out is value-accretive.
• Balance sheet: total debt $17.5B, net debt $17.4B, net-debt/EBITDA 3.8× (TTM reported metric) / ~3.0× on management's FY26 adjusted-EBITDA guide. Investment-grade-ish but genuinely leveraged; debt/equity is optically extreme (6×) because equity is thin. Interest coverage ~5×. Current ratio 0.72 (normal for midstream).

6. Valuation — priced in or room?

TRGP is not cheap on any near-term measure: 26× trailing EPS, 4.6× EV/sales, 15× EV/EBITDA, and a >200× price/FCF (capex suppresses FCF). The bull's defense is the forward earnings ramp: on live consensus the P/E steps down 24× (FY26E) → 21× (FY27E) → 18× (FY28E) → 14× (FY30E) as EPS compounds — the multiple compresses even at a flat price if estimates hit. But 15× EV/EBITDA on a ~13% grower with 3× leverage is a full midstream multiple, above where the group has historically traded; the market is already paying for the build-out to succeed. FMP's own letter rating is B / overall score 3, dinged specifically on price-to-earnings (1/5), price-to-book (1/5) and debt-to-equity (1/5) — i.e. valuation and leverage, exactly our concern. Street targets (context): consensus $277, high $331, low $231. Our ~$270 base sits at consensus — we see fair, not cheap. Not a value buy; a quality-at-full-price name to accumulate on weakness.

7. Technicals (from the tech block)

• Trend: up but cooling. $258.88 sits just below the 50-DMA ($261.46) and well above the 200-DMA ($211.56) — the longer-term uptrend is intact but short-term momentum has stalled. MACD +0.69 (marginally positive).
• Location: −6.5% off the 52-week high ($276.75), +77% off the 52-week low ($146.30); max drawdown from peak only −6.5% — a shallow, orderly pullback, not a breakdown.
• Momentum: RSI(14) 41 — neutral, neither overbought nor oversold. No stretched-entry warning; also no washed-out bargain signal.
• Relative strength: TRGP +50.5% 12-mo vs SPY +20.6% and QQQ +30.3% — strong trailing outperformance — but +5.8% 3-mo vs SPY +13.7% and QQQ +22.0%, i.e. it has lagged over the last quarter as the entry cooled.
• Read: technicals are consistent with the Watch call — a leadership name that has run hard, now consolidating below its 50-DMA with neutral RSI. No urgency to chase; a reclaim of the 50-DMA on volume, or a deeper pullback toward the rising 200-DMA (~$212), would be cleaner entries.

8. Moat & competitive position

Targa's moat is infrastructure position, not brand: an integrated Permian-to-Gulf-Coast footprint (~28,000+ miles of gas pipelines, 40+ processing plants, Mont Belvieu fractionation, LPG-export docks) that is expensive, permit-gated and time-consuming to replicate, and that captures fee-based margin at multiple points along the NGL value chain. The integrated G&P-to-export chain is the durable advantage — volumes gathered upstream feed Targa's own fractionation and export capacity downstream. The vulnerability is concentration: heavy reliance on Permian producer activity and on a fee/commodity mix that softens when drilling slows. Switching costs are real once a producer is connected, but the underlying volumes are ultimately a bet on Permian economics.

Peer set (market cap): Energy Transfer $67B, ONEOK $55B (the closest large-cap G&P/NGL comp), Cheniere Partners $30B, EQT $33B, Diamondback $48B, Occidental $49B, Cenovus $46B, Woodside $37B, Pembina $27B, Plains All American $16B. Against ONEOK and Energy Transfer, TRGP carries the richest multiple and the strongest recent growth — justified only if Permian volumes and export margins hold.

9. Management, capital allocation & guidance

• Capital allocation: growth-first — ~$4.5B/yr net growth capex into the Permian/Mont Belvieu build-out, alongside a 25%-raised dividend ($1.25/qtr, $5.00/yr annualized, ~1.9% yield) and opportunistic buybacks ($55M in Q1'26; $1.32B remaining authorization). Because capex + dividend + buyback exceed free cash flow, the shortfall is debt-funded — appropriate only while projects earn above their cost of capital, and a real risk if volumes disappoint.
• Insider activity: the sampled Form 4s (Mar–May 2026) are routine dispositions — executive/director open-market sales ($239–$256, e.g. CCO Muraro, director Crisp) plus gifts and tax-withholding in-kind transactions. No insider buying in the window; a normal-diversification pattern, mildly unsupportive but not alarming.
• Management's own guidance (half-weighted — their self-interested words). From Targa's SEC 8-K / Item 2.02 earnings release filed 2026-05-07 (a real earnings release, not boilerplate): management raised the FY2026 outlook to adjusted EBITDA of $5.7–5.9B, a ~17% YoY increase at the midpoint, citing marketing/optimization upside, LPG-export strength and broad volume growth; reaffirmed ~$4.5B net growth capex and ~$250M maintenance capex; reported record Q1'26 adjusted EBITDA of $1.40B (+19% YoY), record Permian inlet and fractionation volumes; and noted Q2'26 Permian inlet volumes "trending significantly higher" than Q1. We take this as a genuine, positive operational signal — but half-weighted, as management is talking its own book, and note their FCF math still relies on continued debt funding.

10. Catalysts & what to watch

• Next earnings: 2026-08-06 (Q2'26; Street EPS $2.74, revenue ~$4.8B). Key lines: adjusted EBITDA vs the raised $5.7–5.9B guide, Permian inlet volumes (management flagged Q2 "significantly higher"), and LPG-export throughput after the Q1 outage.
• Permian volume trajectory & oil price: the master variable — sustained producer activity vs price-related curtailments (which already bit Q1'26).
• Project execution: on-time/on-budget ramp of Train 12/13 fractionators, Roadrunner III / Copperhead II plants (2028), and NGL-pipeline/export expansions.
• Deleveraging: whether net-debt/adjusted-EBITDA trends toward the low-3s/high-2s as EBITDA scales, or the build-out keeps it elevated.
• Capital returns: further dividend growth and buyback pace vs FCF.

Thesis tripwires (what would change the call): a sustained oil-price break that curtails Permian drilling; two quarters of volume/EBITDA misses vs guide; leverage rising back above ~4×; or a cost/schedule blow-out on the major projects. A meaningful pullback toward the 200-DMA (~$212) that widens base-case upside would, conversely, argue for an upgrade.

11. Key risks

• Commodity & volume cyclicality (structural): this is a Permian-levered energy business — the 2020–21 net losses show it can swing negative in a downturn. Price-related producer curtailments already dented Q1'26.
• Leverage: ~3× net-debt/adjusted-EBITDA (3.8× on the TTM reported metric) into a capital-intensive build-out; a cyclical EBITDA dip would raise the ratio and pressure the equity fast.
• Valuation / de-rating: 24× forward EPS and 15× EV/EBITDA on ~13% growth leave little margin for error; the group has historically traded cheaper.
• Thin free cash flow: capex + dividend + buyback exceed FCF, so capital returns lean on continued debt issuance — fine while accretive, fragile if not.
• Single-basin concentration: heavy Permian dependence; a basin-specific slowdown hits volumes disproportionately.
• No expert corroboration: unlike our conviction-track names, there is no independent Synthos KB voice to cross-check this thesis — the call rests entirely on quant + fundamentals + management's own (self-interested) guidance.

12. Verdict, position sizing & monitoring

Watch. Targa is a genuinely well-run midstream operator with a real Permian NGL tailwind, expanding fee-based EBITDA margin (30.4% TTM), record volumes, and management raising guidance (FY26 adjusted EBITDA $5.7–5.9B, +17%). But the market already knows this: the stock has re-rated to ~24× forward EPS and 15× EV/EBITDA, our base-case fair value (~$270) sits essentially at the Street's $277 consensus for only ~4% upside, and the name carries ~3× leverage with thin free cash flow into a capex-heavy build-out. That is a hold-and-monitor, not a buy, at $258.88.

• Sizing: if owned, a satellite income/energy position, ~1–2% — for the ~1.9% growing dividend plus mid-teens EPS compounding, not for a re-rating. Accumulate on weakness (toward the 200-DMA ~$212), not on strength.
• Monitoring: re-underwrite on the §10 tripwires; formal re-score each earnings print, with special attention to volumes-vs-guide and the leverage trajectory. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $258.88.
• Single biggest risk: Permian volume/commodity cyclicality colliding with ~3× leverage and a full multiple.

Provenance & disclosures

• Traceability: 0 KB claims, breadth 0 — no expert coverage; the verdict is explicitly fundamentals- and quant-driven, with no claim_ids to cite. Fabricated conviction is structurally impossible (there is nothing to reconcile, and we say so).
• Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-03 · management guidance from the SEC 8-K filed 2026-05-07. Forward figures are analyst consensus (FMP) or management guidance, each labeled as an estimate.
• Management caveat: the FY2026 adjusted-EBITDA guidance is management's own book, half-weighted by design.
• Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
• Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").